Impax Asset Management Group PLC Travere Therapeutics, Inc. Transaction History
Impax Asset Management Group PLC
- $15.6 Billion
- Q2 2025
A detailed history of Impax Asset Management Group PLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 475,000 shares of TVTX stock, worth $13.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
475,000
Previous 300,000
58.33%
Holding current value
$13.2 Million
Previous $5.38 Million
30.77%
% of portfolio
0.05%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding TVTX
# of Institutions
233Shares Held
101MCall Options Held
1.71MPut Options Held
401K-
Janus Henderson Group PLC London, X09.54MShares$266 Million0.07% of portfolio
-
Armistice Capital, LLC New York, NY8.88MShares$248 Million2.3% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$213 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$167 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C35.1MShares$142 Million0.1% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.79B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...